Clinical Impact of Combined Modified Glasgow Prognostic Score and C-Reactive Protein/Albumin Ratio in Patients with Colorectal Cancer
Son, W.; Shin, S.-J.; Park, S.H.; Lee, S.K.; Park, E.J.; Baik, S.H.; Lee, K.Y.; Kang, J. Clinical Impact of Combined Modified Glasgow Prognostic Score and C-Reactive Protein/Albumin Ratio in Patients with Colorectal Cancer. Diagnostics 2020, 10, 859. https://doi.org/10.3390/diagnostics10110859
Son W, Shin S-J, Park SH, Lee SK, Park EJ, Baik SH, Lee KY, Kang J. Clinical Impact of Combined Modified Glasgow Prognostic Score and C-Reactive Protein/Albumin Ratio in Patients with Colorectal Cancer. Diagnostics. 2020; 10(11):859. https://doi.org/10.3390/diagnostics10110859
Chicago/Turabian StyleSon, Woosung, Su-Jin Shin, Su H. Park, Soo K. Lee, Eun J. Park, Seung H. Baik, Kang Y. Lee, and Jeonghyun Kang. 2020. "Clinical Impact of Combined Modified Glasgow Prognostic Score and C-Reactive Protein/Albumin Ratio in Patients with Colorectal Cancer" Diagnostics 10, no. 11: 859. https://doi.org/10.3390/diagnostics10110859


